Angel Ayuso-Sacido
Overview
Explore the profile of Angel Ayuso-Sacido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carrillo-Beltran D, Nahuelpan Y, Cuevas C, Fabres K, Silva P, Zubieta J, et al.
Cells
. 2025 Feb;
14(3).
PMID: 39936970
Glioblastoma (GB) is a highly malignant brain tumor with a poor prognosis, with a median survival of only 14.6 months despite aggressive treatments. Resistance to chemotherapy, particularly temozolomide (TMZ), is...
2.
Palacin-Aliana I, Garcia-Romero N, Carrion-Navarro J, Puig-Serra P, Torres-Ruiz R, Rodriguez-Perales S, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456686
The isolation of circulating tumoral DNA (ctDNA) present in the bloodstream brings about the opportunity to detect genomic aberrations from the tumor of origin. However, the low amounts of ctDNA...
3.
Bibiano Guillen M, Tolsdorf Rodriguez J, Nunez-Alfonsel J, Cardenas-Rebollo J, Ayuso-Sacido A
Healthcare (Basel)
. 2024 Aug;
12(16).
PMID: 39201118
In the healthcare field, the effective implementation of clinical protocols is crucial to ensuring patient safety and well-being. In this context, this study evaluates nurses' adherence to the maintenance and...
4.
Villoch-Fernandez J, Martinez-Garcia N, Martin-Lopez M, Maeso-Alonso L, Lopez-Ferreras L, Vazquez-Jimenez A, et al.
Mol Oncol
. 2024 Aug;
19(3):852-877.
PMID: 39090849
Glioblastoma (GB) is the most common and fatal type of primary malignant brain tumor for which effective therapeutics are still lacking. GB stem cells, with tumor-initiating and self-renewal capacity, are...
5.
Penate L, Carrillo-Beltran D, Spichiger C, Cuevas-Zhbankova A, Torres-Arevalo A, Silva P, et al.
Pharmaceuticals (Basel)
. 2024 May;
17(5).
PMID: 38794149
Glioblastoma (GB) is the most aggressive and common primary malignant tumor of the brain and central nervous system. Without treatment, the average patient survival time is about six months, which...
6.
Cortes-Llanos B, Rauti R, Ayuso-Sacido A, Perez L, Ballerini L
Biomolecules
. 2023 May;
13(5).
PMID: 37238653
Nanomaterials design, synthesis, and characterization are ever-expanding approaches toward developing biodevices or neural interfaces to treat neurological diseases. The ability of nanomaterials features to tune neuronal networks' morphology or functionality...
7.
Peris-Celda M, Carrion-Navarro J, Palacin-Aliana I, Sanchez-Gomez P, Prat Acin R, Garcia-Romero N, et al.
Front Oncol
. 2022 Sep;
12:923681.
PMID: 36091108
Gliomas are the most common brain tumors, which present poor prognosis, due, in part, to tumor cell migration and infiltration into distant brain areas. However, the underlying mechanisms causing such...
8.
Erices J, Niechi I, Uribe-Ojeda A, Toro M, Garcia-Romero N, Carrion-Navarro J, et al.
Front Oncol
. 2022 Sep;
12:969993.
PMID: 36059665
Glioblastoma (GBM) is the most common and deadly malignant brain tumor, with a median survival of 15 to 17 months for a patient. GBM contains a cellular subpopulation known as...
9.
Rodriguez-Pascual J, Ayuso-Sacido A, Belda-Iniesta C
Cancer Drug Resist
. 2022 May;
2(4):980-993.
PMID: 35582274
Recent advances in pharmacological immune modulation against tumor cells has dramatically changed the paradigm of cancer treatment. Checkpoint inhibitor therapy is a form of cancer immunotherapy already in clinical setting...
10.
Pienkowski T, Kowalczyk T, Garcia-Romero N, Ayuso-Sacido A, Ciborowski M
Biochim Biophys Acta Rev Cancer
. 2022 Mar;
1877(3):188721.
PMID: 35304294
The diagnosis of glioma is mainly based on imaging methods that do not distinguish between stage and subtype prior to histopathological analysis. Patients with gliomas are generally diagnosed in the...